ZimVie (NASDAQ:ZIMV) Updates FY 2025 Earnings Guidance

ZimVie (NASDAQ:ZIMV) updated its FY 2025 earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of 0.800-0.950 for the period, compared to the consensus estimate of 0.750. The company issued revenue guidance of $445.0 million-$460.0 million, compared to the consensus revenue estimate of $458.0 million.

ZimVie Stock Performance

ZimVie stock traded down $0.09 during mid-day trading on Wednesday, reaching $13.10. The company had a trading volume of 185,894 shares, compared to its average volume of 249,283. The company has a quick ratio of 1.38, a current ratio of 1.94 and a debt-to-equity ratio of 0.57. The company has a 50 day moving average of $13.77 and a 200-day moving average of $14.81. ZimVie has a 52 week low of $12.70 and a 52 week high of $22.40. The firm has a market cap of $361.55 million, a price-to-earnings ratio of -1.00 and a beta of 2.10.

About ZimVie

ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.